Item 8.01 Other Events.

On October 21, 2009, Delcath Systems, Inc. (the "Company") issued a press release announcing that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.

A copy of the press release, dated October 21, 2009, is attached as Exhibit 99.1 to this Current Report on Form 8-K amd is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed with this report on Form 8-K:

Exhibit Number Description of Exhibit
99.1 Press Release of Delcath Systems, Inc. dated October 21, 2009

---